Context:
The Supreme Court of India is examining the feasibility of making Nucleic Acid Testing (NAT) mandatory in blood banks to improve blood transfusion safety. The case highlights concerns over HIV infections in patients, including Thalassemia children, due to contaminated blood transfusions and argues that safe blood is part of the fundamental right to life under Article 21.
Key Highlights:
Judicial Intervention
- The Supreme Court is assessing whether NAT screening should be mandatory in blood banks across India.
- The petition was filed by Sarvesham Mangalam Foundation, advocating safe blood transfusion as a constitutional right.
Need for Improved Screening
- NAT is a highly sensitive molecular test capable of detecting viral infections earlier than conventional methods.
- It can detect:
- HIV
- Hepatitis B
- Hepatitis C
Concerns Highlighted
- Several cases reported HIV transmission through blood transfusion in Madhya Pradesh and Jharkhand.
- Thalassemia patients, who require frequent blood transfusions, are particularly vulnerable.
Cost and Feasibility Debate
- The Court is examining:
- Cost implications for state governments
- Extent of NAT usage in public hospitals
- Current screening in many blood banks relies on ELISA tests, which are cheaper but less sensitive.
Significance
- Strengthening blood safety standards.
- Ensuring public health protection and medical accountability.
- Reinforcing the constitutional obligation of the state to protect life and health.
Relevant Prelims Points:
- Nucleic Acid Testing (NAT)
- A molecular diagnostic technique that detects viral genetic material (DNA/RNA).
- Allows early detection of infections during the “window period” before antibodies appear.
- Used for screening HIV, Hepatitis B, and Hepatitis C.
- ELISA (Enzyme-Linked Immunosorbent Assay)
- A commonly used immunological test that detects antibodies or antigens.
- Less sensitive during the window period of infections compared to NAT.
- Thalassemia
- A genetic blood disorder causing abnormal haemoglobin production.
- Patients require regular blood transfusions for survival.
- India has one of the largest numbers of thalassemia patients globally.
- Article 21 – Right to Life
- Guarantees protection of life and personal liberty.
- The Supreme Court has expanded its interpretation to include:
- Right to health
- Right to medical care
- Right to safe blood transfusion.
Relevant Mains Points:
Public Health Challenges in Blood Transfusion
- Inconsistent screening standards across blood banks.
- Limited adoption of advanced diagnostic technologies due to cost constraints.
- High burden of blood-transfusion-dependent diseases like thalassemia.
Importance of NAT Implementation
- Early detection of viral infections, reducing transfusion-related infections.
- Improves blood safety and patient protection.
- Aligns India with global standards in transfusion medicine.
Policy and Governance Issues
- Balancing cost considerations with public health priorities.
- Ensuring uniform standards across states and healthcare facilities.
- Strengthening regulation of blood banks under the Drugs and Cosmetics Act.
Way Forward
- Gradual phased implementation of NAT testing across blood banks.
- Financial support to states for upgrading testing infrastructure.
- Strengthening National Blood Policy implementation.
- Increasing public awareness and voluntary blood donation.
UPSC Relevance:
- Prelims: NAT test, ELISA test, Thalassemia, Article 21.
- Mains: Public health governance, blood safety regulations, right to health under the Constitution.